Evidence map›Paper›PMID 26884057›Full record

ArticleMolecular imaging and biology2016

Evaluation of Quantitative Imaging Biomarkers in the DSS Colitis Model.

Anne Beltzer, Thomas Kaulisch, Teresa Bluhmki, Tanja Schoenberger, Birgit Stierstorfer, Detlef Stiller

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anne BeltzerDiv. Research Germany-Target Discovery Research, In-Vivo Imaging Laboratory, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397, Biberach an der Riß, Germany.
Thomas KaulischDiv. Research Germany-Target Discovery Research, In-Vivo Imaging Laboratory, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397, Biberach an der Riß, Germany.
Teresa BluhmkiDiv. Research Germany-Target Discovery Research, In-Vivo Imaging Laboratory, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397, Biberach an der Riß, Germany.
Tanja SchoenbergerTarget Discovery Research, Target Validation Technologies, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
Birgit StierstorferTarget Discovery Research, Target Validation Technologies, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
Detlef StillerDiv. Research Germany-Target Discovery Research, In-Vivo Imaging Laboratory, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397, Biberach an der Riß, Germany. detlef.stiller@boehringer-ingelheim.com.
Boehringer Ingelheim (Germany) · DETarget (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn humans, colonoscopy is the gold standard for the diagnosis of inflammatory changes of the colon wall. Aim of this study was the identification of less invasive imaging biomarkers in the dextran sodium sulfate (DSS) colitis model to provide additional information on transmural changes of the colon wall. PROCEDURES: Colitis was induced in C57BL/6 mice by administration of 2, 3, and 4 % DSS over a period of 5 days. Colon wall thickness was measured using magnetic resonance imaging (MRI), ultrasound (US), and x-ray computed tomography (CT), gut inflammation by positron emission tomography/CT, and mucosal changes of the colon wall by colonoscopy. Colon samples were examined histologically.

resultsMRI, CT, US, and histological data revealed increased colon wall thickness in DSS-treated mice compared to healthy controls. Elevated 2-deoxy-2[(18)F]fluoro-D-glucose uptake and colonoscopy confirmed high inflammatory load in the guts of colitis mice.

conclusionsThe established quantitative imaging readouts offer promising perspectives to develop new compounds and to translate these methods into the clinical setting.

Indexed as

AnimalsBiomarkersColitisColonDextran SulfateDiagnostic ImagingFemaleInflammationMice, Inbred C57BLBiomarkersDextran SulfateColitisDSSInflammatory bowel diseaseMouse modelMultimodal imaging

Identifiers

PMID26884057
OpenAlexW2341712361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.